Keywords: fda, initiate, full, review, bio-technology, general, oxandrin

FDA To Initiate Full Review Of Bio-Technology General's Oxandrin

Article | 04 November 1996

Print This

- Bio-Technology General of Israel has been advised by the US Food and Drug Administration that it is to initiate the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in